Researchers have identified azole compounds, especially talarozole, as promising drug candidates for Leigh syndrome by combining deep learning computational screening with human brain organoid models derived from patient cells. Original paper: Accelerating Leigh syndrome drug discovery through deep learning screening in brain organoids. — Nature Communications. 10.1038/s41467-026-71391-2 📄 Read the article